SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Public-private partnerships: an overview
1 references·4 citing·25 second hop
Public-private partnerships: an overview (2005)Public-private partnerships: an overviewVirtual drug discovery and development for neglected diseases through public–private partnerships (2003)Virtual drug discovery and de…A means of improving public health in low- and middle-income countries? Benefits and challenges of international public–private partnerships (2017)A means of improving public h…Public‐Private Partnerships in Hong Kong: Good Governance – The Essential Missing Ingredient?1 (2010)Public‐Private Partnerships i…Policies and Incentives for Promoting Innovation in Antibiotic Research (2010)Policies and Incentives for P…Macrosocial Determinants of Population Health in the Context of Globalization (2007)Macrosocial Determinants of P…The Demand for Health: A Theoretical and Empirical Investigation (1975)The price of innovation: new estimates of drug development costs (2003)Demand-pull, technology-push, and government-led incentives for non-incremental technical change (2009)Research and development of antibiotics: insights from patents and citation network (2016)What are the economic barriers of antibiotic R&D and how can we overcome them? (2018)Social Conditions As Fundamental Causes of Disease (1995)Neighborhoods and Violent Crime: A Multilevel Study of Collective Efficacy (1997)Human Development Report (2001)Build-operate-transfer model for infrastructure developments in Asia: reasons for successes and failures (1999)United Nations Millennium Declaration (2001)Investing in development : a practical plan to achieve the Millennium Development Goals (2005)Rethinking public participation in infrastructure projects (2012)The challenges of fractionalized property rights in public‐private hybrid organizations: The good, the bad, and the ugly (2015)Relationships among Value-for-Money Drivers of Public–Private Partnership Infrastructure Projects (2019)Global public-private partnerships: Part I--A new development in health? (2000)Seven habits of highly effective global public–private health partnerships: Practice and potential (2006)The GAVI Alliance and the ‘Gates approach’ to health system strengthening (2014)PUBLIC-PRIVATE PARTNERSHIPS IN HEALTH SECTOR INNOVATION: LESSONS FROM AROUND THE WORLD (2024)Public-private partnerships in health sector innovation: Lessons from around the world (2024)Collaborative innovation during the drug discovery and development process (2025)Cost of innovation in the pharmaceutical industry (1991)Drug development for neglected diseases: a deficient market and a public-health policy failure (2002)Priority medicines for Europe and the world (2004)Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression (2009)Exploring different approaches to improve the success of drug discovery and development projects: a review (2020)
this work references cited by second hop

References

  • 2003Virtual drug discovery and development for neglected diseases through public–private partnerships259 cited

Cited by

  • 2010Policies and Incentives for Promoting Innovation in Antibiotic Research102 cited
  • 2017A means of improving public health in low- and middle-income countries? Benefits and challenges of international public–private partnerships53 cited
  • 2010Public‐Private Partnerships in Hong Kong: Good Governance – The Essential Missing Ingredient?152 cited
  • 2007Macrosocial Determinants of Population Health in the Context of Globalization15 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work